Combined oral contraceptive pills for treatment of acne.
暂无分享,去创建一个
[1] S. Taneepanichskul,et al. Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen , 2011, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[2] W. Koltun,et al. Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis. , 2011, European journal of obstetrics, gynecology, and reproductive biology.
[3] W. Cunliffe,et al. Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial. , 2009, Contraception.
[4] E. Palombo-Kinne,et al. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate , 2009, Journal of Family Planning and Reproductive Health Care.
[5] M. Niknian,et al. Treatment of Acne Using a 3-Milligram Drospirenone/20-Microgram Ethinyl Estradiol Oral Contraceptive Administered in a 24/4 Regimen: A Randomized Controlled Trial , 2008, Obstetrics and gynecology.
[6] D. Thiboutot,et al. Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial. , 2008, Contraception.
[7] U. Winkler,et al. Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol. , 2004, Contraception.
[8] M. Curran,et al. Ethinylestradiol/Chlormadinone Acetate , 2004, Drugs.
[9] B. Djulbegovic,et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review , 2003, BMJ : British Medical Journal.
[10] M. Rosen,et al. A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris. , 2003, American journal of obstetrics and gynecology.
[11] R. Farmer,et al. Differences in the use of combined oral contraceptives amongst women with and without acne. , 2003, Human reproduction.
[12] T. Kealey,et al. Modelling the remission of individual acne lesions in vitro , 2002, The British journal of dermatology.
[13] R. Lobo,et al. The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne1 , 2002, Journal of endocrinological investigation.
[14] J. Leyden,et al. Efficacy of a low-dose oral contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial , 2002 .
[15] T. Poyner,et al. Commentary: A UK primary care perspective on treating acne. , 2002, BMJ.
[16] H. Baldwin. The interaction between acne vulgaris and the psyche. , 2002, Cutis.
[17] J. Fiet,et al. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12‐month randomized trial , 2002, The British journal of dermatology.
[18] A. Linneberg,et al. Have Oral Contraceptives Reduced the Prevalence of Acne? A Population-Based Study of Acne vulgaris, Tobacco Smoking and Oral Contraceptives , 2002, Dermatology.
[19] S. Kreiner,et al. Oral contraceptives and venous thromboembolism: a five-year national case-control study. , 2002, Contraception.
[20] Kenneth F Schulz,et al. Blinding in randomised trials: hiding who got what , 2002, The Lancet.
[21] Kenneth F Schulz,et al. Allocation concealment in randomised trials: defending against deciphering , 2002, The Lancet.
[22] Karen A Robinson,et al. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. , 2002, International journal of epidemiology.
[23] B. Dréno,et al. An epidemiological study of acne in female adults: results of a survey conducted in France , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.
[24] H. Jick,et al. Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives , 2001, The Lancet.
[25] J. Andreas,et al. Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara®) and EE/LNG (Microgynon®) , 2001, Dermatology.
[26] D. Thiboutot,et al. A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment , 2001 .
[27] Candace S. Brown,et al. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. , 2001, Journal of women's health & gender-based medicine.
[28] M. Flack,et al. Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgaris. , 2001 .
[29] J. DiGiovanna,et al. Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials. , 2001, Contraception.
[30] D. Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.
[31] Masahiko Toyoda,et al. Pathogenesis of acne , 2001, Medical Electron Microscopy.
[32] M. Vartiainen,et al. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate , 2001, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[33] C. Burkhart,et al. Effects of Benzoyl Peroxide on Lipogenesis in Sebaceous Glands Using an Animal Model , 2000, Journal of cutaneous medicine and surgery.
[34] C. Paul,et al. Oral contraceptives and fatal pulmonary embolism , 2000, The Lancet.
[35] D. Thiboutot,et al. New treatments and therapeutic strategies for acne. , 2000, Archives of family medicine.
[36] J. Foidart,et al. Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone , 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[37] D. Whiting,et al. Effect of a desogestrel-containing oral contraceptive on the skin , 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[38] A. Kowald,et al. Inhibition of skin 5α-reductase by oral contraceptive progestins in vitro , 2000 .
[39] D. Archer,et al. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®) , 1999 .
[40] K. Bradshaw,et al. Effect of low-dose oral contraceptives on androgenic markers and acne. , 1999, Contraception.
[41] W J Cunliffe,et al. Prevalence of facial acne in adults. , 1999, Journal of the American Academy of Dermatology.
[42] G. Grubb,et al. Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. A multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms). , 1999, Contraception.
[43] Olson Wh,et al. The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris. , 1998 .
[44] L. Bahamondes,et al. Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene. , 1998, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[45] G. Heinze,et al. Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial. , 1998, Archives of dermatology.
[46] M. Lebwohl,et al. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. , 1997, Journal of the American Academy of Dermatology.
[47] J. Leyden,et al. Therapy for acne vulgaris. , 1997, The New England journal of medicine.
[48] J. Jorizzo,et al. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. , 1997 .
[49] D. Thiboutot,et al. Hormonal Therapy for Acne , 1996, Seminars in cutaneous medicine and surgery.
[50] W. Feichtinger,et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. , 1996, Contraception.
[51] W. Doesburg,et al. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate. , 1996, International journal of fertility and menopausal studies.
[52] L. Falsetti,et al. An open randomized comparative study of an oral contraceptive containing ethinyl estradiol and cyproterone acetate with and without the GnRH analogue goserelin in the long-term treatment of hirsutism. , 1996, Gynecologic and obstetric investigation.
[53] G. Miggiano,et al. Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris. , 1996, Contraception.
[54] T. Braunschweig,et al. The influence of Microgynon and Diane-35, two sub-fifty ovulation inhibitors, on voice function in women. , 1995, Contraception.
[55] W. Bergfeld. The evaluation and management of acne: economic considerations. , 1995, Journal of the American Academy of Dermatology.
[56] S. Koetsawang,et al. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women. , 1995, Contraception.
[57] Schindler Ae,et al. Die ovarielle Suppression unter Diane 35/50 , 1994 .
[58] H. Bennink,et al. The effects of CTR-24, a biphasic oral contraceptive combination, compared to Diane-35 in women with acne. , 1994, Contraception.
[59] J. Cove,et al. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic‐sensitive and ‐resistant skin bacteria from acne patients , 1994, The British journal of dermatology.
[60] A. Genazzani,et al. Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel. , 1994, European journal of obstetrics, gynecology, and reproductive biology.
[61] F. Weber-Diehl,et al. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial. , 1993, Contraception.
[62] R. Lobo,et al. Effects of sex steroids on skin 5 alpha-reductase activity in vitro. , 1991, Obstetrics and gynecology.
[63] J. Wishart. AN OPEN STUDY OF TRIPHASIL AND DIANE 50 IN THE TREATMENT OF ACNE , 1991, The Australasian journal of dermatology.
[64] R. Percival-Smith,et al. Cyproterone acetate/ethinyl estradiol in the treatment of acne. A comparative dose-response study of the estrogen component. , 1990, Contraception.
[65] R. Erkkola,et al. Ovulatlon Inhibitors Containing Cyproterone Acetate Or Desogestrel In The Treatment Of Hyperandrogenic Symptoms , 1990, Acta obstetricia et gynecologica Scandinavica.
[66] R. Derman,et al. [Clinical evidence of the minimal androgenic activity of norgestimate]. , 1989, Revue francaise de gynecologie et d'obstetrique.
[67] R. Rubens,et al. Effects of cyproterone acetate plus ethinylestradiol low dose on plasma androgens and lipids in mildly hirsute or acneic young women. , 1988, Contraception.
[68] J. Mehrl. [Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent--acne therapeutic drug is effective as a contraceptive]. , 1988, Fortschritte der Medizin.
[69] B. Green,et al. Efficacy of low‐dose cyproterone acetate compared with minocycline in the treatment of acne vulgaris , 1987, Clinical and experimental dermatology.
[70] U. Lachnit-Fixson,et al. [Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane]. , 1986, Fortschritte der Medizin.
[71] F. Wojnarowska,et al. Anti‐androgen treatment in women with acne: a controlled trial , 1986, The British journal of dermatology.
[72] L. Carlborg. Cyproterone Acetate Versus Levonorgestrel Combined with Ethinyl Estradiol in the Treatment of Acne: Results of a multicenter study * , 1986, Acta obstetricia et gynecologica Scandinavica. Supplement.
[73] W. Cunliffe,et al. Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment. , 1985, British medical journal.
[74] I. Sivin,et al. A randomized double blind study of two oral contraceptives. , 1979, Contraception.
[75] U. Lachnit-Fixson. THE DEVELOPMENT AND EVALUATION OF AN OVULATION INHIBITOR (DIANE®) CONTAINING AN ANTIANDROGEN , 1979, Acta obstetricia et gynecologica Scandinavica. Supplement.
[76] U. Lachnit-Fixson,et al. [Therapy of androgenization symptoms: double blind study of an antiandrogen preparation (SH B 209 AB) against neogynon (author's transl)]. , 1977, Medizinische Klinik.
[77] A. Libroia,et al. Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol. , 1976, Acta Europaea fertilitatis.
[78] E. Grund,et al. [The treatment of virilizing syndromes. Comparative clinical studies of 2 antiandrogen-active gestagens (cyproterone acetate, megestrol acetate]. , 1975, Die Medizinische Welt.
[79] C. Gerlinger,et al. Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women , 2010, Clinical drug investigation.
[80] C. Westhoff,et al. Pharmacology of hormonal contraceptives and acne. , 2008, Cutis (New York, N.Y.).
[81] P. Rich. Hormonal contraceptives for acne management. , 2008, Cutis.
[82] D. Gruber,et al. A Comparison of the Cycle Control, Safety, and Efficacy Profile of a 21-Day Regimen of Ethinylestradiol 20μg and Drospirenone 3mg with a 21-Day Regimen of Ethinylestradiol 20μg and Desogestrel 150μg , 2006, Treatments in endocrinology.
[83] K. Fotherby,et al. New progestogens in oral contraception. , 1994, Contraception.
[84] M. Mancone,et al. [Oral contraceptives and their minor side effects: comparison of three low-dose estroprogestinic combinations]. , 1987, Patologia e clinica ostetrica e ginecologica.
[85] M. Reinilä,et al. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne. , 1986, Acta dermato-venereologica.
[86] P. Ylöstalo,et al. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives. , 1984, Acta dermato-venereologica.